Validation of a novel CT perfusion software compared to RAPID in stroke patients receiving endovascular therapy

验证一种新型CT灌注软件与RAPID软件在接受血管内治疗的卒中患者中的应用

阅读:1

Abstract

Accurate estimate of ischemic core volume (ICV) and penumbra volume (PV) is important in decision-making for endovascular therapies (EVT) and predicting the patient's clinical outcome. In this study, we compared the performance of a novel automated CT perfusion software UGuard and the Rapid Processing of Perfusion and Diffusion (RAPID). UGuard and RAPID had strong agreement with regard to ICV (ICC 0.92, 95% CI 0.89 - 0.94) and PV (ICC 0.8, 95% CI 0.73 - 0.85) measurements. ICVs measured by UGuard or RAPID were similar in predicting favorable outcome (AUC 0.72 vs. 0.70, P = 0.43), with UGuard measurements having higher specificity. After adjusting for significant clinical covariates, the predictive performance of favorable outcome was excellent for each of the six models incorporating ICV and PV, and the model which incorporated ICV and PV measured by UGuard software package showed the best predictive performance. We concluded that the ICV and PV of CT perfusion images measured by UGuard software package, as well as the capacity to predict favorable outcome of patients following EVT, were comparable to RAPID.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。